阿特罗平加上奥梅普拉治疗急性胃炎:疗效和安全性分析
1Jian'ou Municipal Hospital, Nanping, Fujian, China.
Pakistan journal of pharmaceutical sciences
|January 12, 2025
概括
与安尼索达胺相比,阿特罗平加奥梅普拉在急性胃炎治疗中显示出更高的疗效和安全性. 这种组合疗法显著改善了症状,并减少了炎症标志物.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 急性胃炎 (AG) 是一个重大的临床挑战.
- 目前的治疗选择需要进一步优化疗效和安全.
研究的目的:
- 评估阿特罗平 (ATR) 加上奥梅普拉 (OME) 在治疗急性胃炎中的疗效和安全性.
- 为了比较这种联合治疗与安尼索达胺 (ADM) 加上OME.
主要方法:
- 一项涉及95名AG患者的比较研究 (2022年5月至2024年5月).
- 观察组 (n=50) 接受了ATR+OME;对照组 (n=45) 接受了ADM+OME.
- 分析包括临床疗效,安全性,症状缓解,炎症因素 (TNF-α,IL-6,IFN-β) 和胃肠道激素 (EGF,GAS,SS).
主要成果:
- 在ATR+OME组显示较高的总有效率和更快的症状缓解 (胃痛,腹部张张,恶心,吐).
- 在ATR+OME组中观察到较低的不良反应 (,心跳,头痛) 发生率.
- 与基线和对照相比,ATR+OME显著降低了TNF-α,IL-6,IFN-β和GAS,同时增加了EGF和SS.
结论:
- 阿特罗平加上奥梅普拉在急性胃炎治疗中表现出显著的疗效和高临床安全性.
- 这种组合疗法为治疗急性胃炎提供了进一步的临床推广.
相关概念视频
Peptic Ulcer Disease IV: Management
71
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
71
Gastritis III: Clinical Manifestations and Management
150
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
150
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
340
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
340
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
404
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
404
Gastroesophageal Reflux Disease II: Clinical Features and Management
54
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
54
Cholinergic Antagonists: Therapeutic Uses
708
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
708


